US Medical Bionic Implant Artificial Organs Market

ID: MRFR/MED/17450-HCR
100 Pages
Nidhi Mandole
Last Updated: April 06, 2026
US Medical Bionic Implant Artificial Organs Market Research Report: Size, Share, Trend Analysis By Technology (Mechanical, Electronic Bionics), By Products (Vision, Ear, Orthopedic, Heart, Neural/Brain), By Fixation (Implantable, Externally Worn) and By End-User (Hospitals, Clinics, Research and Academic Institutes) - Growth Outlook & Industry Forecast 2025 To 2035
US Medical Bionic Implant Artificial Organs Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)5.69%
2024 Market Size$ 6 Billion
2025 Market Size$ 6.34 Billion
2035 Market Size$ 11.04 Billion
Key Players
Medtronic
Abbott Laboratories
Boston Scientific
Edwards Lifesciences
Stryker Corporation
Cochlear Limited
Opportunities
  • Advancements in Biomaterials
  • Rising Prevalence of Chronic Diseases
  • Increased Investment in Healthcare Technology
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Chemicals and Materials, BY Technology (USD Billion)
      1. 4.1.1 Mechanical
      2. 4.1.2 Electronic
    2. 4.2 Chemicals and Materials, BY Products (USD Billion)
      1. 4.2.1 Vision
      2. 4.2.2 Ear
      3. 4.2.3 Orthopedic
      4. 4.2.4 Heart
      5. 4.2.5 Neural/Brain
    3. 4.3 Chemicals and Materials, BY Fixation (USD Billion)
      1. 4.3.1 Implantable
      2. 4.3.2 Externally Worn
    4. 4.4 Chemicals and Materials, BY End-User (USD Billion)
      1. 4.4.1 Hospitals
      2. 4.4.2 Clinics
      3. 4.4.3 Research and Academic Institutes
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Medtronic (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Abbott Laboratories (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Boston Scientific (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Edwards Lifesciences (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Stryker Corporation (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Cochlear Limited (AU)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 B. Braun Melsungen AG (DE)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Zimmer Biomet Holdings (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY TECHNOLOGY
    3. 6.3 US MARKET ANALYSIS BY PRODUCTS
    4. 6.4 US MARKET ANALYSIS BY FIXATION
    5. 6.5 US MARKET ANALYSIS BY END-USER
    6. 6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
    9. 6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    11. 6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
    12. 6.12 CHEMICALS AND MATERIALS, BY TECHNOLOGY, 2024 (% SHARE)
    13. 6.13 CHEMICALS AND MATERIALS, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
    14. 6.14 CHEMICALS AND MATERIALS, BY PRODUCTS, 2024 (% SHARE)
    15. 6.15 CHEMICALS AND MATERIALS, BY PRODUCTS, 2024 TO 2035 (USD Billion)
    16. 6.16 CHEMICALS AND MATERIALS, BY FIXATION, 2024 (% SHARE)
    17. 6.17 CHEMICALS AND MATERIALS, BY FIXATION, 2024 TO 2035 (USD Billion)
    18. 6.18 CHEMICALS AND MATERIALS, BY END-USER, 2024 (% SHARE)
    19. 6.19 CHEMICALS AND MATERIALS, BY END-USER, 2024 TO 2035 (USD Billion)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
      2. 7.2.2 BY PRODUCTS, 2025-2035 (USD Billion)
      3. 7.2.3 BY FIXATION, 2025-2035 (USD Billion)
      4. 7.2.4 BY END-USER, 2025-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Medical Bionic Implant Artificial Organs Market Segmentation

US Medical Bionic Implant Artificial Organs Market By Technology (USD Billion, 2025-2035)

  • Mechanical
  • Electronic

US Medical Bionic Implant Artificial Organs Market By Products (USD Billion, 2025-2035)

  • Vision
  • Ear
  • Orthopedic
  • Heart
  • Neural/Brain

US Medical Bionic Implant Artificial Organs Market By Fixation (USD Billion, 2025-2035)

  • Implantable
  • Externally Worn

US Medical Bionic Implant Artificial Organs Market By End-User (USD Billion, 2025-2035)

  • Hospitals
  • Clinics
  • Research and Academic Institutes
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.